During the performance of several types of spinal surgical procedures, some spine surgeons utilize a bone graft substitute, Bone Morphogenetic Protein, to stimulate spinal fusion. One such product is INFUSE® Bone Graft, which is manufactured by Medtronic. Counsel to these patients claim that the product is defective, causing bony overgrowth and consequently injury to the spine. Counsel have commenced thousands of product liability lawsuits against the manufacturer, Medtronic, and many of these suits include the spine surgeon as a party defendant.
Martin Clearwater & Bell LLP is currently defending such parties in these types of lawsuits, and has extensive experience in representing physicians and health care facilities in product liability cases.